Quantitative HBeAg varies in the different phases of HBV infection, and can predict therapeutic outcome in the setting of immunosuppression driven HBV reactivation
Piermatteo, Lorenzo, Salpini, Romina, Alkhatib, Mohammad, Bertoli, Ada, Iuvara, Alessandra, De Cristofaro, Maria, Cappiello, Giuseppina, Cerva, Carlotta, Minichini, Carmine, Starace, Mario, Pisaturo,Volume:
73
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(20)31663-9
Date:
August, 2020
File:
PDF, 59 KB
2020